Alcor Expands Cryonics Services With Membership Growth
Alcor Life Extension Foundation, led by CEO James Arrowood, serves about 1,600 members and reported roughly $4 million in 2024 revenue, with user fees making up about 40 percent. The Scottsdale nonprofit maintains roughly 250 cryopreserved patients and charges about $220,000 for whole-body and $80,000 for neuropreservation, while expanding operations internationally amid rising investor interest. Critics note no human has been revived from cryopreservation to date.
Key Points
- 1Reports Alcor serves about 1,600 members and maintains roughly 250 cryopreserved patients.
- 2Highlights growing wealthy investor interest and $4M 2024 revenue, signaling financial backing and credibility.
- 3Implies practitioners should track cryonics data, regulatory, and preservation-tech developments for future applications.
Scoring Rationale
Balanced reporting of Alcor’s membership, finances, and investor interest, but niche longevity focus limits broader industry impact.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
